Health

STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 05/11/2026, 01:52:24 UTC.

Briefings

The Wall Street Journal reports that CVS Health is splitting into two entities: one housing Aetna and Caremark, the other containing 9,000 retail pharmacies. This breakup, planned for early 2028, follows a near-$70 billion merger that created a healthcare giant. The article also notes a significant increase in FDA unannounced drug inspections in India and China during Fiscal Year 2026, with inspection parity between domestic and international facilities being a key goal.

Key points

• CVS Health is splitting into two entities: one housing Aetna and Caremark, the other containing 9,000 retail pharmacies.
• The breakup is planned for early 2028, occurring a decade after the near-$70 billion merger that created the current healthcare giant.

Context

The article discusses CVS Health's planned split and FDA inspection increases in India and China. No additional background on the company's history or the specific regulatory context is supplied beyond the provided text.

Limitations

Evidence is limited to the provided article text; no external data or additional context is available. The article does not specify the exact date of the planned split beyond 'early 2028', and the source does not provide details on the specific reasons for the split beyond the reversal of a signature deal.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 05/11/2026, 10:40:07 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiamecziyzkq3e4bqypqbvfrsr3g2k6u6uor67xgem5eil647hpo5a